{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T08:03:52Z","timestamp":1771661032663,"version":"3.50.1"},"reference-count":168,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Corona virus disease 2019 (COVID-19) imposes a serious public health pandemic affecting the whole world, as it is spreading exponentially. Besides its high infectivity, SARS-CoV-2 causes multiple serious derangements, where the most prominent is severe acute respiratory syndrome as well as multiple organ dysfunction including heart and kidney injury. While the deleterious impact of SARS-CoV-2 on pulmonary and cardiac systems have attracted remarkable attention, the adverse effects of this virus on the renal system is still underestimated. Kidney susceptibility to SARS-CoV-2 infection is determined by the presence of angiotensin-converting enzyme 2 (ACE2) receptor which is used as port of the viral entry into targeted cells, tissue tropism, pathogenicity and subsequent viral replication. The SARS-CoV-2 cellular entry receptor, ACE2, is widely expressed in proximal epithelial cells, vascular endothelial and smooth muscle cells and podocytes, where it supports kidney integrity and function via the enzymatic production of Angiotensin 1-7 (Ang 1-7), which exerts vasodilatory, anti-inflammatory, antifibrotic and diuretic\/natriuretic actions via activation of the Mas receptor axis. Loss of this activity constitutes the potential basis for the renal damage that occurs in COVID-19 patients. Indeed, several studies in a small sample of COVID-19 patients revealed relatively high incidence of acute kidney injury (AKI) among them. Although SARS-CoV-1 -induced AKI was attributed to multiorgan failure and cytokine release syndrome, as the virus was not detectable in the renal tissue of infected patients, SARS-CoV-2 antigens were detected in kidney tubules, suggesting that SARS-CoV-2 infects the human kidney directly, and eventually induces AKI characterized with high morbidity and mortality. The mechanisms underlying this phenomenon are largely unknown. However, the fact that ACE2 plays a crucial role against renal injury, the deprivation of the kidney of this advantageous enzyme, along with local viral replication, probably plays a central role. The current review focuses on the critical role of ACE2 in renal physiology, its involvement in the development of kidney injury during SARS-CoV-2 infection, renal manifestations and therapeutic options. The latter includes exogenous administration of Ang (1-7) as an appealing option, given the high incidence of AKI in this ACE2-depleted disorder, and the benefits of ACE2\/Ang1-7 including vasodilation, diuresis, natriuresis, attenuation of inflammation, oxidative stress, cell proliferation, apoptosis and coagulation.<\/jats:p>","DOI":"10.3390\/jcm10061216","type":"journal-article","created":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T11:38:58Z","timestamp":1615808338000},"page":"1216","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Renal Manifestations of Covid-19: Physiology and Pathophysiology"],"prefix":"10.3390","volume":"10","author":[{"given":"Zaher","family":"Armaly","sequence":"first","affiliation":[{"name":"Department of Nephrology, Nazareth Hospital, EMMS, Nazareth 16100, Israel"},{"name":"The Bar-Ilan University Azrieli Faculty of Medicine, Safed 1311502, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safa","family":"Kinaneh","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Nazareth Hospital, EMMS, Nazareth 16100, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Skorecki","sequence":"additional","affiliation":[{"name":"The Bar-Ilan University Azrieli Faculty of Medicine, Safed 1311502, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,3,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.2162","article-title":"The emerging role of ACE2 in physiology and disease","volume":"212","author":"Hamming","year":"2007","journal-title":"J. Pathol."},{"key":"ref_2","unstructured":"Brenner., B. (2003). Control of extracellular fluid volume and pathophysiology of edema formation. The Kidney, W.B. Saunders. [7th ed.]."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1161\/CIRCRESAHA.120.317055","article-title":"COVID-19 and the Heart","volume":"126","author":"Akhmerov","year":"2020","journal-title":"Circ. Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00424-012-1120-0","article-title":"ACE2, angiotensin-(1\u20137), and Mas: The other side of the coin","volume":"465","author":"Bader","year":"2013","journal-title":"Pfl\u00fcgers Archiv. Eur. J. Physiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"307315","DOI":"10.1155\/2012\/307315","article-title":"Angiotensin-Converting Enzyme 2: The First Decade","volume":"2012","author":"Clarke","year":"2012","journal-title":"Int. J. Hypertens."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1113\/expphysiol.2008.042002","article-title":"Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis","volume":"93","author":"Santos","year":"2008","journal-title":"Exp. Physiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1681\/ASN.2006090986","article-title":"ACE2: A new target for prevention of diabetic nephropathy?","volume":"17","author":"Ingelfinger","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A Novel Angiotensin-Converting Enzyme\u2013Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Li, Z., Yi, Y., Luo, X., Xiong, N., Liu, Y., Li, S., Sun, R., Wang, Y., Hu, B., and Chen, W. (2020). Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis. J. Med. Virol.","DOI":"10.1002\/jmv.25727"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1126\/science.abb2762","article-title":"Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2","volume":"367","author":"Yan","year":"2020","journal-title":"Science"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"H1080","DOI":"10.1152\/ajpheart.00215.2020","article-title":"Letter to the Editor: Angiotensin-converting enzyme 2: An ally or a Trojan horse? Implications to SARS-CoV-2-related cardiovascular complications","volume":"318","author":"Abassi","year":"2020","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"L1020","DOI":"10.1152\/ajplung.00097.2020","article-title":"Covid-19 infection and mortality: A physiologist\u2019s perspective enlightening clinical features and plausible interventional strategies","volume":"318","author":"Abassi","year":"2020","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1681\/ASN.2006050423","article-title":"Glomerular Localization and Expression of Angiotensin-Converting Enzyme 2 and Angiotensin-Converting Enzyme: Implications for Albuminuria in Diabetes","volume":"17","author":"Ye","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/path.1670","article-title":"Renal ACE2 expression in human kidney disease","volume":"204","author":"Lely","year":"2004","journal-title":"J. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1042\/CS20090554","article-title":"ACE2-angiotensin-(1-7)-Mas axis in renal ischaemia\/reperfusion injury in rats","volume":"119","author":"Diniz","year":"2010","journal-title":"Clin. Sci. (Lond.)"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/sj.ki.5000321","article-title":"ACE and ACE2: Their role to balance the expression of angiotensin II and angiotensin-(1-7)","volume":"70","author":"Chappel","year":"2006","journal-title":"Kidney Int."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"H1985","DOI":"10.1152\/ajpheart.01145.2002","article-title":"Systemic and regional hemodynamic effects of angiotensin-(1\u20137) in rats","volume":"284","author":"Sampaio","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/hy0302.104673","article-title":"Vasodilator action of angiotensin-(1-7) on isolated rabbit afferent arterioles","volume":"39","author":"Ren","year":"2002","journal-title":"Hypertension"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0167-0115(01)00322-6","article-title":"Angiotensin-(1-7) reverts the stimulatory effect of angiotensin II on the proximal tubule Na(+)-ATPase activity via a A779-sensitive receptor","volume":"103","author":"Lara","year":"2002","journal-title":"Regul. Pept."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/01.HYP.27.4.875","article-title":"Evidence for a Physiological Role of Angiotensin-(1-7) in the Control of Hydroelectrolyte Balance","volume":"27","author":"Santos","year":"1996","journal-title":"Hypertension"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00424-003-1173-1","article-title":"Angiotensin-(1\u20137) stimulates water transport in rat inner medullary collecting duct: Evidence for involvement of vasopressin V2 receptors","volume":"447","author":"Magaldi","year":"2003","journal-title":"Pfl\u00fcgers Arch."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/00005344-199807000-00025","article-title":"[7-D-ALA]-angiotensin 1-7 blocks renal actions of angiotensin 1-7 in the anesthetized rat","volume":"32","author":"Vallon","year":"1998","journal-title":"J. Cardiovasc. Pharm."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0167-0115(98)00038-X","article-title":"Diuresis and natriuresis produced by long term administration of a selective Angiotensin-(1-7) antagonist in normotensive and hypertensive rats","volume":"74","author":"Bello","year":"1998","journal-title":"Regul. Pept."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1038\/sj.ki.5001509","article-title":"Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells","volume":"69","author":"Su","year":"2006","journal-title":"Kidney Int."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"F1297","DOI":"10.1152\/ajprenal.00110.2010","article-title":"The ANG-(1-7)\/ACE2\/mas axis in the regulation of nephron function","volume":"298","author":"Ferrario","year":"2010","journal-title":"Am. J. Physiol Ren. Physiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/ki.2009.61","article-title":"Genetic deletion of the angiotensin-(1-7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria","volume":"75","author":"Pinheiro","year":"2009","journal-title":"Kidney Int."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"414128","DOI":"10.1155\/2012\/414128","article-title":"Angiotensin converting enzyme 2, Angiotensin-(1-7), and receptor MAS axis in the kidney","volume":"2012","author":"Pinheiro","year":"2012","journal-title":"Int. J. Hypertens."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Esteban, V., Heringer-Walther, S., Sterner-Kock, A., de Bruin, R., van den Engel, S., Wang, Y., Mezzano, S., Egido, J., Schultheiss, H.P., and Ruiz-Ortega, M. (2009). Angiotensin-(1-7) and the g protein-coupled receptor MAS are key players in renal inflammation. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0005406"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/MNH.0b013e3280123c0e","article-title":"The emerging role of angiotensin-converting enzyme-2 in the kidney","volume":"16","author":"Burns","year":"2007","journal-title":"Curr. Opin. Nephrol. Hypertens"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"848","DOI":"10.2337\/diacare.29.04.06.dc05-1873","article-title":"Tissue gene expression of renin-angiotensin system in human type 2 diabetic nephropathy","volume":"29","author":"Konoshita","year":"2006","journal-title":"Diabetes Care"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1053\/j.ajkd.2007.11.022","article-title":"Expression of ACE and ACE2 in individuals with diabetic kidney disease and healthy controls","volume":"51","author":"Mizuiri","year":"2008","journal-title":"Am. J. Kidney Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.2337\/db06-0033","article-title":"ACE and ACE2 activity in diabetic mice","volume":"55","author":"Wysocki","year":"2006","journal-title":"Diabetes"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/01.HYP.0000060689.38912.CB","article-title":"Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy","volume":"41","author":"Tikellis","year":"2003","journal-title":"Hypertension"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/sj.ki.5002373","article-title":"ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice","volume":"72","author":"Soler","year":"2007","journal-title":"Kidney Int."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.2353\/ajpath.2006.051091","article-title":"Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis","volume":"168","author":"Oudit","year":"2006","journal-title":"Am. J. Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2353\/ajpath.2007.060977","article-title":"Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury","volume":"171","author":"Wong","year":"2007","journal-title":"Am. J. Pathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000108758","article-title":"Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats","volume":"28","author":"Benter","year":"2008","journal-title":"Am. J. Nephrol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"E262","DOI":"10.1152\/ajpendo.90678.2008","article-title":"Chronic infusion of angiotensin-(1-7) improves insulin resistance and hypertension induced by a high-fructose diet in rats","volume":"296","author":"Giani","year":"2009","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"F1271","DOI":"10.1152\/ajprenal.00065.2010","article-title":"Attenuating effect of angiotensin-(1-7) on angiotensin II-mediated NAD(P)H oxidase activation in type 2 diabetic nephropathy of KK-A(y)\/Ta mice","volume":"300","author":"Moon","year":"2011","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"808726","DOI":"10.1155\/2012\/808726","article-title":"Renoprotective Effects of AVE0991, a Nonpeptide Mas Receptor Agonist, in Experimental Acute Renal Injury","volume":"2012","author":"Barroso","year":"2012","journal-title":"Int. J. Hypertens."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1172\/JCI16980","article-title":"Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice","volume":"116","author":"Gurley","year":"2006","journal-title":"J. Clin. Invest."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/sj.ki.5000428","article-title":"Developmental expression of ACE2 in the SHR kidney: A role in hypertension?","volume":"70","author":"Tikellis","year":"2006","journal-title":"Kidney Int."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"H2166","DOI":"10.1152\/ajpheart.00061.2006","article-title":"Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats","volume":"291","author":"Jessup","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.2353\/ajpath.2008.070762","article-title":"Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK\/p38 MAP kinase pathway","volume":"172","author":"Koka","year":"2008","journal-title":"Am. J. Pathol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/en.2006-1287","article-title":"Synergistic expression of angiotensin-converting enzyme (ACE) and ACE2 in human renal tissue and confounding effects of hypertension on the ACE to ACE2 ratio","volume":"148","author":"Wakahara","year":"2007","journal-title":"Endocrinology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/HYPERTENSIONAHA.110.164244","article-title":"Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2","volume":"57","author":"Zhong","year":"2011","journal-title":"Hypertension"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1203\/01.pdr.0000246100.14061.bc","article-title":"Circulating renin Angiotensin system in childhood chronic renal failure: Marked increase of Angiotensin-(1-7) in end-stage renal disease","volume":"60","author":"Diniz","year":"2006","journal-title":"Pediatr. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/CMR.00102-14","article-title":"Middle East respiratory syndrome coronavirus: Another zoonotic betacoronavirus causing SARS-like disease","volume":"28","author":"Chan","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Lam, T.T., Shum, M.H., Zhu, H.C., Tong, Y.G., Ni, X.B., Liao, Y.S., Wei, W., Cheung, W.Y., Li, W.J., and Li, L.F. (2020). Identifying SARS-CoV-2 related coronaviruses in Malayan pangolins. Nature.","DOI":"10.1101\/2020.02.13.945485"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., and Xiong, Y. (2020). Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA.","DOI":"10.1001\/jama.2020.1585"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Ikizler, T.A. (2020). COVID-19 and Dialysis Units: What Do We Know Now and What Should We Do?. Am. J. Kidney Dis.","DOI":"10.1053\/j.ajkd.2020.03.008"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","article-title":"Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury","volume":"395","author":"Russell","year":"2020","journal-title":"Lancet"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S2213-2600(20)30060-6","article-title":"Coronavirus epidemic: Preparing for extracorporeal organ support in intensive care","volume":"8","author":"Ronco","year":"2020","journal-title":"Lancet Respir Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.coviro.2018.01.001","article-title":"Transmission routes of respiratory viruses among humans","volume":"28","author":"Kutter","year":"2018","journal-title":"Curr. Opin. Virol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.coviro.2011.12.003","article-title":"Environmental factors affecting the transmission of respiratory viruses","volume":"2","author":"Pica","year":"2012","journal-title":"Curr. Opin. Virol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"493960","DOI":"10.1155\/2013\/493960","article-title":"Aerobiology and its role in the transmission of infectious diseases","volume":"2013","author":"Fernstrom","year":"2013","journal-title":"J. Pathog."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1371\/journal.ppat.0030151","article-title":"Influenza virus transmission is dependent on relative humidity and temperature","volume":"3","author":"Lowen","year":"2007","journal-title":"PLoS Pathog."},{"key":"ref_63","first-page":"479","article-title":"Airborne micro-organisms: Survival tests with four viruses","volume":"59","author":"Harper","year":"1961","journal-title":"J. Hyg. (Lond.)"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"S737","DOI":"10.1098\/rsif.2009.0227.focus","article-title":"The effect of environmental parameters on the survival of airborne infectious agents","volume":"6","author":"Tang","year":"2009","journal-title":"J. R. Soc. Interface"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"105924","DOI":"10.1016\/j.ijantimicag.2020.105924","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges","volume":"55","author":"Lai","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s40620-020-00719-y","article-title":"Hospitals as health factories and the coronavirus epidemic","volume":"33","author":"Piccoli","year":"2020","journal-title":"J. Nephrol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"m641","DOI":"10.1136\/bmj.m641","article-title":"Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate","volume":"368","author":"Mahase","year":"2020","journal-title":"BMJ"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.kint.2020.03.005","article-title":"Kidney disease is associated with in-hospital death of patients with COVID-19","volume":"97","author":"Cheng","year":"2020","journal-title":"Kidney Int."},{"key":"ref_71","unstructured":"Li, Z., Wu, M., Yao, J., Guo, J., Liao, X., Song, S., Li, J., Duan, G., Zhou, Y., and Wu, X. (2002). Caution on Kidney Dysfunctions of COVID-19 Patients. medRxiv."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical Characteristics of Coronavirus Disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00134-020-05979-7","article-title":"Critical care crisis and some recommendations during the COVID-19 epidemic in China","volume":"46","author":"Xie","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Young, B.E., Ong, S.W.X., Kalimuddin, S., Low, J.G., Tan, S.Y., Loh, J., Ng, O.T., Marimuthu, K., Ang, L.W., and Mak, T.M. (2020). Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore. JAMA.","DOI":"10.1001\/jama.2020.3204"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/resp.12854","article-title":"Low-grade endotoxemia and clotting activation in the early phase of pneumonia","volume":"21","author":"Cangemi","year":"2016","journal-title":"Respirology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1136\/thoraxjnl-2015-207178","article-title":"Nox2 up-regulation is associated with an enhanced risk of atrial fibrillation in patients with pneumonia","volume":"70","author":"Violi","year":"2015","journal-title":"Thorax"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1055\/s-2000-13221","article-title":"Use of D-dimer assays in the diagnosis of venous thrombosis","volume":"26","author":"Dempfle","year":"2000","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e001595","DOI":"10.1161\/JAHA.114.001595","article-title":"Lower mortality rate in elderly patients with community-onset pneumonia on treatment with aspirin","volume":"4","author":"Falcone","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/jth.14817","article-title":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","volume":"18","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000507471","article-title":"Coronavirus Disease 19 Infection Does Not Result in Acute Kidney Injury: An Analysis of 116 Hospitalized Patients from Wuhan, China","volume":"51","author":"Wang","year":"2020","journal-title":"Am. J. Nephrol."},{"key":"ref_82","unstructured":"Diao, B., Wang, C., Wang, R., Feng, Z., Tan, Y., Wang, H., Wang, C., Liu, L., Liu, Y., and Liu, Y. (2003). Human Kidney is a Target for Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. medRxiv."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Hirsch, J.S., Ng, J.H., Ross, D.W., Sharma, P., Shah, H.H., Barnett, R.L., Hazzan, A.D., Fishbane, S., Jhaveri, K.D., and Abate, M. (2020). Acute kidney injury in patients hospitalized with COVID-19. Kidney Int.","DOI":"10.1016\/j.kint.2020.05.006"},{"key":"ref_84","first-page":"E009","article-title":"A pathological report of three COVID-19 cases by minimal invasive autopsies","volume":"49","author":"Yao","year":"2020","journal-title":"Zhonghua Bing Li Xue Za Zhi Chin. J. Pathol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.kint.2020.04.006","article-title":"Collapsing glomerulopathy in a COVID-19 patient","volume":"98","author":"Kissling","year":"2020","journal-title":"Kidney Int."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ekir.2020.04.002","article-title":"Collapsing Glomerulopathy in a Patient With COVID-19","volume":"5","author":"Larsen","year":"2020","journal-title":"Kidney Int. Rep."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Peleg, Y., Kudose, S., D\u2019Agati, V., Siddall, E., Ahmad, S., Kisselev, S., Gharavi, A., and Canetta, P. (2020). Acute Kidney Injury Due to Collapsing Glomerulopathy Following COVID-19 Infection. Kidney Int. Rep.","DOI":"10.1016\/j.ekir.2020.04.017"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1681\/ASN.2020050558","article-title":"AKI and Collapsing Glomerulopathy Associated with COVID-19 and APOL1 High-Risk Genotype","volume":"31","author":"Wu","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"105932","DOI":"10.1016\/j.ijantimicag.2020.105932","article-title":"Chloroquine and hydroxychloroquine as available weapons to fight COVID-19","volume":"55","author":"Colson","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/cr.2012.165","article-title":"Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model","volume":"23","author":"Yan","year":"2013","journal-title":"Cell Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S1473-3099(03)00806-5","article-title":"Effects of chloroquine on viral infections: An old drug against today\u2019s diseases?","volume":"3","author":"Savarino","year":"2003","journal-title":"Lancet Infect. Dis."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread","volume":"2","author":"Vincent","year":"2005","journal-title":"Virol. J."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Boulware, D.R., Pullen, M.F., Bangdiwala, A.S., Pastick, K.A., Lofgren, S.M., Okafor, E.C., Skipper, C.P., Nascene, A.A., Nicol, M.R., and Abassi, M. (2020). A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. N. Engl. J. Med.","DOI":"10.1056\/NEJMoa2016638"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"m1849","DOI":"10.1136\/bmj.m1849","article-title":"Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: Open label, randomised controlled trial","volume":"369","author":"Tang","year":"2020","journal-title":"BMJ"},{"key":"ref_95","first-page":"215","article-title":"[A pilot study of hydroxychloroquine in treatment of patients with moderate COVID-19]","volume":"49","author":"Chen","year":"2020","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Magagnoli, J., Narendran, S., Pereira, F., Cummings, T., Hardin, J.W., Sutton, S.S., and Ambati, J. (2020). Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19. medRxiv.","DOI":"10.1101\/2020.04.16.20065920"},{"key":"ref_97","unstructured":"America, I.D.S.o. (2020, April 01). Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19. Available online: https:\/\/www.idsociety.org\/practice-guideline\/covid-19-guideline-treatment-and-management."},{"key":"ref_98","unstructured":"Health, N.I.O. (2020, April 01). Coronavirus Disease 2019 (COVID-19) Treatment Guidelines, Available online: https:\/\/www.covid19treatmentguidelines.nih.gov\/."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Geleris, J., Sun, Y., Platt, J., Zucker, J., Baldwin, M., Hripcsak, G., Labella, A., Manson, D., Kubin, C., and Barr, R.G. (2020). Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19. N. Engl. J. Med.","DOI":"10.1056\/NEJMoa2012410"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Chen, C., Pan, K., Wu, B., Li, X., Chen, Z., Xu, Q., and Lv, Q. (2020). Safety of hydroxychloroquine in COVID-19 and other diseases: A systematic review and meta-analysis of 53 randomized trials. Eur J. Clin. Pharm.","DOI":"10.1007\/s00228-020-02962-5"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Misra, S., Nath, M., Hadda, V., and Vibha, D. (2020). Efficacy of various treatment modalities for nCOV-2019: A systematic review and meta-analysis. Eur J. Clin. Invest., e13383.","DOI":"10.1111\/eci.13383"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"eabb5883","DOI":"10.1126\/scitranslmed.abb5883","article-title":"An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice","volume":"12","author":"Sheahan","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Beigel, J.H., Tomashek, K.M., Dodd, L.E., Mehta, A.K., Zingman, B.S., Kalil, A.C., Hohmann, E., Chu, H.Y., Luetkemeyer, A., and Kline, S. (2020). Remdesivir for the Treatment of Covid-19 \u2014 Preliminary Report. N. Engl. J. Med.","DOI":"10.1056\/NEJMoa2007764"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1503\/cmaj.1040398","article-title":"Initial viral load and the outcomes of SARS","volume":"171","author":"Chu","year":"2004","journal-title":"CMAJ"},{"key":"ref_105","first-page":"399","article-title":"Treatment of severe acute respiratory syndrome with lopinavir\/ritonavir: A multicentre retrospective matched cohort study","volume":"9","author":"Chan","year":"2003","journal-title":"Hong Kong Med. J."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"105954","DOI":"10.1016\/j.ijantimicag.2020.105954","article-title":"Cytokine release syndrome in severe COVID-19: Interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality","volume":"55","author":"Zhang","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fmed.2020.00170","article-title":"Use of Corticosteroids in Coronavirus Disease 2019 Pneumonia: A Systematic Review of the Literature","volume":"7","author":"Veronese","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1164\/rccm.201706-1172OC","article-title":"Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome","volume":"197","author":"Arabi","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"108393","DOI":"10.1016\/j.clim.2020.108393","article-title":"The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China","volume":"214","author":"Zhang","year":"2020","journal-title":"Clin. Immunol."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Horby, P., Lim, W.S., Emberson, J.R., Mafham, M., Bell, J.L., Linsell, L., Staplin, N., Brightling, C., Ustianowski, A., and Elmahi, E. (2020). Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. N. Engl. J. Med.","DOI":"10.1101\/2020.06.22.20137273"},{"key":"ref_111","unstructured":"WHO (2020, April 01). WHO Updates Clinical Care Guidance with Corticosteroid Recommendations. Available online: https:\/\/www.who.int\/news-room\/feature-stories\/detail\/who-updates-clinical-care-guidance-with-corticosteroid-recommendations."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/infdis\/jiu396","article-title":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: A systematic review and exploratory meta-analysis","volume":"211","author":"Baillie","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_113","unstructured":"Xu, Z., Zhou, J., Huang, Y., Liu, X., Xu, Y., Chen, S., Liu, D., Lin, Z., Liu, X., and Li, Y. (2002). The efficacy of convalescent plasma for the treatment of severe influenza. medRxiv."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.kint.2020.03.001","article-title":"The Novel Coronavirus 2019 epidemic and kidneys","volume":"97","author":"Naicker","year":"2020","journal-title":"Kidney Int."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1523-1755.2005.67130.x","article-title":"Acute renal impairment in coronavirus-associated severe acute respiratory syndrome","volume":"67","author":"Chu","year":"2005","journal-title":"Kidney Int."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"389","DOI":"10.7326\/M13-2486","article-title":"Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection","volume":"160","author":"Arabi","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1440-1797.2006.00600.x","article-title":"Serum IL-6 and IL-1-ra with sequential organ failure assessment scores in septic patients receiving high-volume haemofiltration and continuous venovenous haemofiltration","volume":"11","author":"Ghani","year":"2006","journal-title":"Nephrol. (Carlton)"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000500013","article-title":"What Have We Learned about the Use of Cytosorb Adsorption Columns?","volume":"48","author":"Ankawi","year":"2019","journal-title":"Blood Purif."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s00134-018-5464-6","article-title":"Hemoadsorption with CytoSorb((R))","volume":"45","author":"Poli","year":"2019","journal-title":"Intensive Care Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000493523","article-title":"A New Series of Sorbent Devices for Multiple Clinical Purposes: Current Evidence and Future Directions","volume":"47","author":"Ankawi","year":"2019","journal-title":"Blood Purif."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1744-9987.2010.00825.x","article-title":"Removal of humoral mediators and the effect on the survival of septic patients by hemoperfusion with neutral microporous resin column","volume":"14","author":"Huang","year":"2010","journal-title":"Ther. Apher Dial."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1744-9987.2012.01083.x","article-title":"Effect on extrapulmonary sepsis-induced acute lung injury by hemoperfusion with neutral microporous resin column","volume":"17","author":"Huang","year":"2013","journal-title":"Ther. Apher Dial."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000507039","article-title":"Coronavirus Epidemic and Extracorporeal Therapies in Intensive Care: Si vis pacem para bellum","volume":"49","author":"Ronco","year":"2020","journal-title":"Blood Purif."},{"key":"ref_124","first-page":"19","article-title":"The effects of recombinant interleukin-1 and recombinant tumor necrosis factor on non-specific resistance to infection","volume":"1","year":"1988","journal-title":"Biotherapy"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.4049\/jimmunol.145.11.3762","article-title":"Requirement of endogenous tumor necrosis factor\/cachectin for recovery from experimental peritonitis","volume":"145","author":"Echtenacher","year":"1990","journal-title":"J. Immunol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000074937","article-title":"Extracorporeal therapies in non-renal disease: Treatment of sepsis and the peak concentration hypothesis","volume":"22","author":"Ronco","year":"2004","journal-title":"Blood Purif."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1046\/j.1525-1594.2003.07289.x","article-title":"Interpreting the mechanisms of continuous renal replacement therapy in sepsis: The peak concentration hypothesis","volume":"27","author":"Ronco","year":"2003","journal-title":"Artif Organs"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/cc9411","article-title":"Clinical review: Blood purification for sepsis","volume":"15","author":"Rimmele","year":"2011","journal-title":"Crit. Care"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13613-019-0530-y","article-title":"Cytokine removal in human septic shock: Where are we and where are we going?","volume":"9","author":"Honore","year":"2019","journal-title":"Ann. Intensive Care"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"e1003258","DOI":"10.1371\/journal.ppat.1003258","article-title":"The secret life of viral entry glycoproteins: Moonlighting in immune evasion","volume":"9","author":"Cook","year":"2013","journal-title":"PLoS Pathog."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"S941","DOI":"10.1093\/infdis\/jir321","article-title":"Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs","volume":"204","author":"Volchkova","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1126\/science.287.5458.1664","article-title":"Epitopes involved in antibody-mediated protection from Ebola virus","volume":"287","author":"Wilson","year":"2000","journal-title":"Science"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Mohan, G.S., Li, W., Ye, L., Compans, R.W., and Yang, C. (2012). Antigenic subversion: A novel mechanism of host immune evasion by Ebola virus. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1003065"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"e1004509","DOI":"10.1371\/journal.ppat.1004509","article-title":"Shed GP of Ebola virus triggers immune activation and increased vascular permeability","volume":"10","author":"Volchkova","year":"2014","journal-title":"PLoS Pathog."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.3201\/eid2210.160218","article-title":"Viral RNA in Blood as Indicator of Severe Outcome in Middle East Respiratory Syndrome Coronavirus Infection","volume":"22","author":"Kim","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1093\/infdis\/jiv351","article-title":"Multidistrict Outbreak of Marburg Virus Disease-Uganda, 2012","volume":"212","author":"Knust","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/infdis\/jiu088","article-title":"Ebola hemorrhagic Fever: Novel biomarker correlates of clinical outcome","volume":"210","author":"McElroy","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.3201\/eid2010.140430","article-title":"Biomarker correlates of survival in pediatric patients with Ebola virus disease","volume":"20","author":"McElroy","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Ewers, E.C., Pratt, W.D., Twenhafel, N.A., Shamblin, J., Donnelly, G., Esham, H., Wlazlowski, C., Johnson, J.C., Botto, M., and Hensley, L.E. (2016). Natural History of Aerosol Exposure with Marburg Virus in Rhesus Macaques. Viruses, 8.","DOI":"10.3390\/v8040087"},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Ajelli, M., and Merler, S. (2012). Transmission potential and design of adequate control measures for Marburg hemorrhagic fever. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0050948"},{"key":"ref_141","unstructured":"ERA-EDTA (2020, April 01). ERA-EDTA Working Group Descartes for Patients Living with a Kidney Transplant. Available online: https:\/\/www.era-edta.org\/en\/covid-19-news-and-information\/#toggle-id-9."},{"key":"ref_142","unstructured":"(2020). Frequently asked questions from transplant candidates and recipients April 6, 2020. Am. Soc. Transplant."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1111\/ajt.15903","article-title":"A familial cluster, including a kidney transplant recipient, of Coronavirus Disease 2019 (COVID-19) in Wuhan, China","volume":"20","author":"Chen","year":"2020","journal-title":"Am. J. Transplant."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1111\/ajt.15874","article-title":"Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation?","volume":"20","author":"Guillen","year":"2020","journal-title":"Am. J. Transplant."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1111\/ajt.15891","article-title":"COVID-19 in kidney transplant recipients","volume":"20","author":"Gandolfini","year":"2020","journal-title":"Am. J. Transplant."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/ajt.15869","article-title":"Successful recovery of COVID-19 pneumonia in a renal transplant recipient with long-term immunosuppression","volume":"20","author":"Zhu","year":"2020","journal-title":"Am. J. Transplant."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.virol.2015.08.010","article-title":"Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome","volume":"485","author":"Torres","year":"2015","journal-title":"Virology"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Akalin, E., Azzi, Y., Bartash, R., Seethamraju, H., Parides, M., Hemmige, V., Ross, M., Forest, S., Goldstein, Y.D., and Ajaimy, M. (2020). Covid-19 and Kidney Transplantation. N. Engl. J. Med.","DOI":"10.1056\/NEJMc2011117"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.kint.2020.04.002","article-title":"A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia","volume":"97","author":"Alberici","year":"2020","journal-title":"Kidney Int."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"8917578","DOI":"10.1155\/2016\/8917578","article-title":"Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease","volume":"2016","author":"Bernardi","year":"2016","journal-title":"J. Diabetes Res."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.lfs.2005.09.038","article-title":"Age- and gender-related difference of ACE2 expression in rat lung","volume":"78","author":"Xie","year":"2006","journal-title":"Life Sci."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"C1169","DOI":"10.1152\/ajpcell.00145.2008","article-title":"MAP kinase\/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides","volume":"295","author":"Gallagher","year":"2008","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/01.HYP.0000124667.34652.1a","article-title":"Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors","volume":"43","author":"Ishiyama","year":"2004","journal-title":"Hypertension"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s10194-020-01106-5","article-title":"Headache medication and the COVID-19 pandemic","volume":"21","author":"MaassenVanDenBrink","year":"2020","journal-title":"J. Headache Pain"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"L17","DOI":"10.1152\/ajplung.00498.2016","article-title":"Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg(9) bradykinin\/BKB1R axis and facilitates LPS-induced neutrophil infiltration","volume":"314","author":"Sodhi","year":"2018","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"19840","DOI":"10.1038\/srep19840","article-title":"Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus","volume":"6","author":"Gu","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.1038\/ncomms4594","article-title":"Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections","volume":"5","author":"Zou","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1097\/00004872-200410000-00020","article-title":"Evidence against a major role for angiotensin converting enzyme-related carboxypeptidase (ACE2) in angiotensin peptide metabolism in the human coronary circulation","volume":"22","author":"Campbell","year":"2004","journal-title":"J. Hypertens."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/00004872-199606000-00017","article-title":"Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension","volume":"14","author":"Luque","year":"1996","journal-title":"J. Hypertens."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Ramchand, J., Patel, S.K., Srivastava, P.M., Farouque, O., and Burrell, L.M. (2018). Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0198144"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jcmg.2019.09.005","article-title":"Plasma ACE2 Activity Predicts Mortality in Aortic Stenosis and Is Associated With Severe Myocardial Fibrosis","volume":"13","author":"Ramchand","year":"2020","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_164","first-page":"1280","article-title":"Angiotensin converting enzyme 2 activity and human atrial fibrillation: Increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling","volume":"19","author":"Walters","year":"2017","journal-title":"Europace"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.cardfail.2009.01.014","article-title":"Soluble angiotensin-converting enzyme 2 in human heart failure: Relation with myocardial function and clinical outcomes","volume":"15","author":"Epelman","year":"2009","journal-title":"J. Card. Fail."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ajh\/hpu086","article-title":"Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker","volume":"28","author":"Furuhashi","year":"2015","journal-title":"Am. J. Hypertens."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Reddy, R., Asante, I., Liu, S., Parikh, P., Liebler, J., Borok, Z., Rodgers, K., Baydur, A., and Louie, S.G. (2019). Circulating angiotensin peptides levels in Acute Respiratory Distress Syndrome correlate with clinical outcomes: A pilot study. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0213096"},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Shi, S., Qin, M., Shen, B., Cai, Y., Liu, T., Yang, F., Gong, W., Liu, X., Liang, J., and Zhao, Q. (2020). Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol.","DOI":"10.1001\/jamacardio.2020.0950"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/6\/1216\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:35:53Z","timestamp":1760160953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/6\/1216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,15]]},"references-count":168,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["jcm10061216"],"URL":"https:\/\/doi.org\/10.3390\/jcm10061216","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,15]]}}}